Novo Holdings — 2015 Investments
1 investments dated 2015 · listed companies and verified rows first · show all
AnaptysBio manages the financial collaborations from Jemperli (with GSK) and imsidolimab (with Vanda), operating a virtual model focused on protecting and returning royalty and milestone value to stockholders.
BiotechSan Diego, US
Robert Hoffman(Executive Officer)inMarco Londei(Executive Officer)inHamza Suria(Executive Officer, Director)inDaniel Faga(President, CEO, and Director)inChristopher Murphy(CFO)
BoardCarol Gallagher(Director)
Co-investorsBioBritFrazier Life SciencesBiotechnology Value FundNorwest Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.